Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

NCT04655612 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04655612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
December 1, 2020
Completion date
July 30, 2021
Enrollment
5,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, covid-19, psoriatic arthritis, rheumatoid arthritis, sars-cov infection, spondyloarthritis